Crescent Grove Advisors, LLC Biovie Inc. Transaction History

Crescent Grove Advisors, LLC

  • $934 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
BUY
$0.53 - $1.89 $4,240 - $15,120
8,000 Added 41.03%
27,500 $14,000
Q4 2023

Jan 30, 2024
BUY
$1.22 - $5.24 $10,370 - $44,540
8,500 Added 77.27%
19,500 $24,000
Q3 2023

Oct 25, 2023
BUY
$2.75 - $5.17 $30,250 - $56,870
11,000 New
11,000 $37,000

Others Institutions Holding BIVI

# of Institutions
45
Shares Held
4.73M
Call Options Held
17.2K
Put Options Held
27K
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $83.6M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Crescent Grove Advisors, LLC Portfolio

Follow Crescent Grove Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crescent Grove Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email